| Literature DB >> 27365554 |
Sayyed Gholam Reza Mortazavi-Moghaddam1, Gholam Reza Sharifzadeh2, Mohammad Reza Rezvani1.
Abstract
The causes and situation of exudative pleural effusion vary from one area to another. A cross-sectional study was conducted on 327 patients with exudative pleural effusion in South Khorasan province (Iran). The patients were older than 12 years and comprised 172 (52.6%) males and 155 (47.4%) females. The study commenced in 2007 with seven years duration. The Light's criteria were used to define exudative effusion. Procedures including pleural fluid analysis, microbiological study, pleural biopsy, and systemic investigations were conducted to determine the special cause of pleural effusion. The mean age of the patients was 63.4±18.4 years. Malignancies, tuberculosis, and parapneumonia pleural exudation were diagnosed in 125 (38.2%), 48 (14.7%), and 45 (13.8%) cases, respectively. Among malignant effusions, metastasis from lung cancer made 48 (38.4%) of the cases. The origin of metastasis was not determined in 44 (35.2%) patients. The mean age of patients was not significantly different between malignant (66.9±14.3 years) and tuberculosis (63.9±19.7 years) cases (P=0.16). The older age of tuberculosis patients could be a new discussion point on the overall impression created on the subject of tuberculosis pleural exudation (TB-PLE) occurring in young people.Entities:
Keywords: Neoplasms; Pleural effusion; Tuberculosis
Year: 2016 PMID: 27365554 PMCID: PMC4912651
Source DB: PubMed Journal: Iran J Med Sci ISSN: 0253-0716
Distribution of exudative effusion etiology in studied patients
| Disease | Frequency (N, %) | Age (years±SD) | Sex (N, %) | Fluid volume (N, %) | ||
|---|---|---|---|---|---|---|
| Male | Female | Massive | Non-massive | |||
| Malignancy | 125 (38.2) | 66.9±14.2 | 59 (47.2) | 66 (52.8) | 73 (58.4) | 52 (41.6) |
| Tuberculosis | 48 (14.7) | 63.9±19.6 | 22 (45.8) | 26 (54.2) | 20 (41.7) | 28 (58.3) |
| Infections | 45 (13.8) | 56.8±21.5 | 28 (62.2) | 17 (37.8) | 15 (33.3) | 30 (66.7) |
| Lymphoma | 12 (3.7) | 45.3±24.5 | 8 (66.7) | 4 (33.3) | 8 (66.7) | 4 (33.3) |
| PTE | 11 (3.4) | 66.3±14.1 | 8 (72.7) | 3 (27.3) | 1 (9.0) | 10 (91.0) |
| CABG | 4 (1.2) | 46.8±18.8 | 2 (50) | 2 (50) | 1 (25) | 3 (75) |
| Pregnancy | 5 (1.5) | 28±5.3 | 0 (0) | 5 (100) | 2 (40) | 3 (60) |
| CTD | 10 (3.1) | 58.9±13.8 | 7 (70.0) | 3 (30) | 5 (50) | 5 (50) |
| Hydatid cyst | 4 (1.2) | 52.2±36.7 | 4 (100) | 0 (0) | 2 (50) | 2 (50) |
| Mesothelioma | 5 (1.5) | 77±12.3 | 3 (60) | 2 (40) | 5 (100) | 0 (0) |
| Unknown | 23 (7) | 67.7±14.8 | 11 (47.8) | 12 (52.2) | 9 (39.1) | 14 (60.9) |
| Not follow up | 29 (8.9) | 72.7±13.7 | 16 (55.2) | 13 (44.8) | 5 (17.2) | 24 (82.8) |
| Miscellaneous | 6 (1.8) | 50.7±21.7 | 4 (66.7) | 2 (33.3) | 4 (66.7) | 2 (33.3) |
| Total | 327 (100) | 63.3±18.5 | 172 (52.6) | 55 (47.4) | 150 (45.9) | 177 (54.1) |
Infection: Parapneumonia and empyema; PTE: Pulmonarythromboembolism; CABG: Coronary artery bypass grafting; CTD: Connective tissue disease
Description of diagnostic criteria in metastatic effusion
| Type of malignancy | Cytopathology (N, %) | Biopsy (N, %) | Metastatic without pleural yield for malignancy (N, %) | Fluid volume (N, %) | ||||
|---|---|---|---|---|---|---|---|---|
| Malignant | Non-malignant | Malignant | Non-malignant | Not taken | Massive | Non-massive | ||
| Lung | 22 (45.8) | 26 (54.2) | 23 (47.9) | 9 (18.8) | 16 (33.3) | 16 (33.3) | 29 (60.4) | 19 (39.6) |
| Breast | 10 (58.8) | 7 (41.2) | 7 (41.2) | 2 (11.8) | 8 (47.1) | 5 (29.4) | 9 (52.9) | 8 (47.1) |
| GI.M | 22 (28.6) | 5 (71.4) | 2 (28.6) | 3 (42.9) | 2 (28.6) | 5 (71.4) | 2 (28.6) | 5 (71.4) |
| GU.M | 1 (16.7) | 5 (83.3) | 3 (50) | 0 (0) | 3 (5) | 3 (50) | 2 (33.3) | 4 (66.7) |
| H&N | 0 (0) | 3 (100) | 1 (33.3) | 1 (33.3) | 1 (33.3) | 2 (66.6) | 1 (33.3) | 2 (66.7) |
| Unknown | 22 (50) | 22 (50) | 28 (63.6) | 3 (6.8) | 13 (29.5) | 11 (25) | 30 (68.2) | 14 (31.8) |
| Total | 57 (45.6) | 68 (54.4) | 64 (51.2) | 18 (14.4) | 43 (34.4) | 42 (33.6) | 73 (58.4) | 52 (41.6) |
GIM: Gastrointestinal malignancy; GUM: Genitourinary malignancy; H&N: Head and Neck malignancy; Unknowns: Metastasis with unknown origin
The origin of pleural metastasis in the studied patients
| Type of malignancy | Frequency (N, %) | Sex (N, %) | Age (years±SD) | Fluid volume (N, %) | ||
|---|---|---|---|---|---|---|
| Male | Female | Massive | Non-massive | |||
| Lung | 48 (38.4) | 29 (60.4) | 19 (39.6) | 68.9±12.8 | 29 (60.4) | 19 (39.6) |
| Breast | 17 (13.6) | 0 (0) | 17 (100) | 54.5±11.9 | 9 (52.9) | 8 (47.1) |
| GI.M | 7 (5.6) | 4 (57.1) | 3 (42.9) | 67.4±11.3 | 2 (28.6) | 5 (71.4) |
| GU.M | 6 (4.8) | 4 (66.7) | 2 (33.3) | 62.5±20.8 | 2 (33.3) | 4 (66.7) |
| H&N | 3 (2.4) | 3 (100) | 0 (0) | 53.3±25.5 | 1 (33.3) | 2 (66.7) |
| Unknown | 44 (35.2) | 19 (43.2) | 25 (56.8) | 71.4±12.0 | 30 (68.2) | 14 (31.8) |
| Total | 125 (100) | 59 (47.2) | 65 (52.8) | 66.8±14.2 | 73 (58.4) | 52 (41.6) |
GIM: Gastrointestinal malignancy; GUM: Genitourinary malignancy; H&N: Head and Neck malignancy; Unknowns: Metastasis with unknown origin
Miscellaneous cause of pleural effusion
| Disease | Frequency (N, %) | Sex (N, %) | Age (years±SD) | Fluid volume (N, %) | ||
|---|---|---|---|---|---|---|
| Male | Female | Massive | Non-massive | |||
| Myelofibrosis | 1 | 1 | 0 | 62 | 1 | 0 |
| Multiple myeloma | 1 | 1 | 0 | 60 | 0 | 1 |
| Lymph edema | 1 | 0 | 1 | 51 | 1 | 0 |
| Hypothyroidism | 1 | 0 | 1 | 23 | 1 | 0 |
| Onicolysis | 1 | 1 | 0 | 51 | 0 | 1 |
| Thymoma | 1 | 1 | 0 | 28 | 1 | 0 |
| Total | 6 | 4 | 2 | 50.7 | 4 | 2 |